Two doctoral students and an undergrad are helping advance the chances of commercializing their professor’s innovation to prevent preterm births, a problem that can lead to severe health problems.

Please provide your email address to receive an email when new articles are posted on . There is no neonatal benefit or harm when using tocolytic drugs for threatened premature birth after 30 weeks’ ...

AURORA, Colo. -- Atosiban, an oxytocin receptor antagonist available in Europe, was not superior to placebo in improving neonatal outcomes for threatened preterm birth between 30 and 34 weeks' ...

In honor of Women’s Health Month, reproductive health researcher and Assistant Professor Scott Barnett from the Department of Biochemistry & Molecular Biology shares the sobering reality of the rising ...

New research finds a link between phthalate exposure and preterm birth. Here's what experts say about it and how you can ...

February 17, 2011 (UPDATED February 27, 2011)— Clinicians should not use injectable terbutaline to prevent preterm labor or treat it beyond 48 to 72 hours because of the risk for maternal heart ...

A typical human pregnancy lasts 40 weeks, but most parents know this number is only a rough estimate. Babies are born on a seemingly unpredictable timeline, with a normal pregnancy ranging from 38 to ...

Increasing the activity level of women with gestational diabetes reduced the risk of preterm labor. Moderate-to-vigorous physical activity (MVPA) during pregnancy is inversely associated with the risk ...

No previous study has been conducted in Nigeria on the role of neutrophil elastase in predicting preterm birth. The present study aimed to determine the role of the neutrophil elastase test in ...

Women's Health. 2008;4(6):625-638. Usage of tocolytics in Europe probably varies from that of the USA. Europeans more often employ the use of tractocile (atosiban), which is an oxytocin receptor ...